Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-15

Clinical Trial Update: SVT-15652 Otic Solution for the Treatment of Otomycosis. [Phase 3]

View source ↗

Summary

Phase 3 trial update for SVT-15652 Otic Solution in otomycosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SVT-15652 Otic Solution

Snippet

Sponsor: Salvat | Conditions: Otomycosis | Phase 3 | Status: COMPLETED | Results posted: 2022-12-15